The pharmaceutical industry constantly seeks high-purity chemical intermediates to drive innovation and develop life-saving medicines. Among these crucial compounds is 3-Methylxanthine, identified by its CAS number 1076-22-8. While its applications extend beyond pharmaceuticals, its role as an intermediate in drug synthesis makes it a compound of significant interest for researchers and pharmaceutical manufacturers.

3-Methylxanthine, known scientifically as 2,6-Dihydroxy-3-methylpurine, is a versatile molecule. Its structural similarity to naturally occurring xanthines, such as caffeine and theobromine, hints at its potential biological interactions and its utility in medicinal chemistry. For companies looking to purchase this compound, understanding its purity requirements is paramount. Typically, pharmaceutical applications demand an assay of ≥99% to ensure the efficacy and safety of the final drug product.

Sourcing 3-Methylxanthine for pharmaceutical development requires a trusted supplier. Manufacturers who can provide consistent quality, adhere to stringent international standards (like USP, BP, EP, FCC), and offer transparent documentation are invaluable. When seeking this intermediate, potential buyers often look for a reliable manufacturer in China, known for its advanced chemical synthesis capabilities and competitive pricing. The opportunity to buy in bulk and receive a detailed quote can significantly impact project timelines and budgets.

Beyond its role as a direct intermediate, 3-Methylxanthine is also studied for its own potential pharmacological activities and as a reference standard in analytical chemistry within pharmaceutical research. Its inclusion in drug discovery pipelines necessitates a dependable supply chain.

For pharmaceutical R&D scientists and procurement specialists, the strategic acquisition of high-purity 3-Methylxanthine (CAS 1076-22-8) is a critical step. By partnering with established chemical suppliers who prioritize quality and offer competitive wholesale prices, the development of new pharmaceutical agents can be significantly advanced. If you are looking to purchase this key intermediate, consider reaching out to experienced manufacturers who can meet your specific needs.